Lightbridge CORP Form 4 insider transactions

Mark Robert Tobin, a Director of LIGHTBRIDGE Corp, sold 15,000 shares of common stock on August 11, 2026 for $8.99 per share.

Daniel B Magraw, a Director of LIGHTBRIDGE Corp, received 10,000 shares of common stock on August 6, 2026.

Mark Robert Tobin, a Director of LIGHTBRIDGE Corp, received 10,000 shares of common stock on August 6, 2026.

Jesse L. Funches, a Director of LIGHTBRIDGE Corp, received 10,000 shares of common stock on August 6, 2026.

Sweta Chakraborty, a Director of LIGHTBRIDGE Corp, received 10,000 shares of common stock on August 6, 2026.

Andrey Mushakov, EVP & Chief Operating Officer of LIGHTBRIDGE Corp, received 84,000 shares of common stock on August 6, 2026.

Seth Grae, President and CEO and a Director of LIGHTBRIDGE Corp, received 105,000 shares of common stock on August 6, 2026.

Larry Goldman, CFO of LIGHTBRIDGE Corp, received 65,000 shares of common stock on August 6, 2026.

Scott Randall Holcombe, SVP & Chief Technology Officer of LIGHTBRIDGE Corp, reported multiple transactions in common stock on August 6, 2026.

Sherri Goodman, a Director at Lightbridge Corp, has sold 1,116 shares of common stock as part of a pre-arranged Rule 10b5-1 trading plan.

Lightbridge Corp CFO Larry Goldman reports a transaction involving shares withheld for taxes upon vesting of performance-based awards.

Andrey Mushakov, EVP of Nuclear Operations at Lightbridge Corp, reported a transaction involving the withholding of shares to cover taxes upon vesting of performance-based restricted stock awards.

Seth Grae, President and CEO of Lightbridge Corp, reports transactions involving the withholding of shares for tax coverage and the status of vested stock options.

Lightbridge Corporation's EVP of Nuclear Operations, Andrey Mushakov, sold 30,289 shares of common stock in pre-planned transactions.

Lightbridge Corporation's CFO, Larry Goldman, sold 8,869 shares of common stock in two transactions in mid-January 2026, pursuant to a pre-arranged 10b5-1 trading plan.

Lightbridge Corporation Director Jesse L. Funches sold 1,449 shares of common stock for a weighted average price of $16.9582 per share.

Lightbridge Corp Director Sweta Chakraborty sold 1,245 shares of common stock for $15.6773 per share under a pre-arranged trading plan.

Lightbridge Corp. Director Mark Tobin was granted 10,631 shares of common stock, vesting throughout 2026.

Lightbridge Corp. Director Daniel B. Magraw was granted 10,631 shares of common stock as an equity award, vesting through 2026.

Lightbridge Corporation Director Jesse L. Funches was granted 10,631 shares of common stock, vesting over 2026.

Lightbridge Corporation Director Sweta Chakraborty reported a sale of 1,947 common shares and an acquisition of 10,631 shares through an equity grant.

Lightbridge Corp. Director Sherri Goodman was granted 10,631 shares of common stock, vesting throughout 2026.

Lightbridge Corporation's CFO, Larry Goldman, reported the sale of 5,451 common shares and the withholding of 8,487 shares for tax purposes.

Andrey Mushakov, EVP of Nuclear Operations at Lightbridge Corp, reported a disposition of 8,104 common shares to cover taxes on restricted stock vesting, retaining 419,371 shares.

Lightbridge Corp's President and CEO, Seth Grae, reported 12,993 shares withheld to cover tax obligations upon the vesting of restricted stock awards.

Lightbridge Corp's CFO, Larry Goldman, reported the sale of 8,030 shares under a 10b5-1 plan and the withholding of 12,500 shares for tax purposes.

Lightbridge Corporation's EVP of Nuclear Operations, Andrey Mushakov, reported a disposition of 11,936 common shares for tax withholding purposes related to vested restricted stock awards.

Lightbridge Corporation's President and CEO, Seth Grae, reported a disposition of 19,137 common shares to cover taxes upon the vesting of restricted stock awards.

Lightbridge Corporation's EVP of Nuclear Operations, Andrey Mushakov, was granted 50,442 restricted stock awards, vesting over three years.

Lightbridge Corporation director Sweta Chakraborty sold 1,948 shares of common stock for approximately $15.47 per share, as part of a pre-arranged trading plan.